(Report ID: 2509527)Many drug interactions and side effects can not be detected until the drugs have been used by millions of people, and for a long time. Large, long-term drug safety studies are ideal to discover these real-world drug outcomes. For the first time, eHealthMe enables health professionals and patients to conduct these studies for their drugs. Click here to check your drugs now, in a whole new way. As of Nov, 20, 2008, eHealthMe analyzes 10,180,583 drug interactions and side effects of 21,667 FDA-approved drugs from 1977 to the present. Results on Nov, 20, 2008: 2 relevant incidents
Note:
- The incidents can not include all actual occurrences
- Data of 2008 is not complete
DISCLAIMER: All adverse drug reaction material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.Basic information:
| Report ID | Date of submission | Patient age | Patient gender |
| 2509527 | Sep, 7, 2008 | 23 | Female |
List of drugs the patient takes:
| Reason for the drug | Drug | Ingredients | Company |
PCOS | Loestrin 21 1.5/30 - 0.03MG;1.5MG | ethinyl estradiol; norethindrone acetate | Warner Chilcott |
Hidradenitis | Pentoxifylline - 400MG | pentoxifylline | Actavis Elizabeth |
Hidradenitis | Spironolactone - 25MG | spironolactone | Actavis Elizabeth |
List of drug interactions, adverse side effects / events the patient has:
| Name | Severity |
Loose Stools | moderate |
Muscle Cramps | severe |
Irritability | moderate |
Results from eHealthMe: 2 relevent incidents1) Comparison with the patient's adverse outcomes:
| Name | Count (% of total reports) |
Loose Stools | 1 (50.00%) |
Muscle Cramps | 1 (50.00%) |
Irritability | 1 (50.00%) |
2) Top drug interactions, adverse side effects reported for the past 12 months:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Irritability | 1 (100.00%) |
2 | Muscle Cramps | 1 (100.00%) |
3 | Loose Stools | 1 (100.00%) |
3) Top co-used drugs reported for the past 12 months:
4) Top drug interactions, adverse side effects reported of all time:Death: 0 Cancer: 0
| Name | Count (% of total reports) |
1 | Leukocytoclastic Vasculitis | 1 (50.00%) |
2 | Irritability | 1 (50.00%) |
3 | Muscle Cramps | 1 (50.00%) |
4 | Loose Stools | 1 (50.00%) |
5) Top co-used drugs reported of all time:
| Name | Count |
1 | Tramadol Hcl | 1 |
2 | Aldactone | 1 |
3 | Aranesp | 1 |
4 | Equanil | 1 |
5 | Levothyroxine Sodium | 1 |
6 | Ferrous Sulfate Tab | 1 |
7 | Insulatard Nph Human | 1 |
8 | Plavix | 1 |
9 | Calciparine | 1 |
10 | Bisoprolol Fumarate | 1 |
Want to have a risk analysis report like this for your drugs? Click here. ADVERTISEMENT
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Recent drug risk analysis reports:
Klonopin (Roche) - 2MG for Neuralgia (Nov, 20, 2008)
|
Metformin Hydrochloride (Alphapharm) ... for Diabetes - Type 2 (Nov, 20, 2008)
|
Side effects comparison of Metformin Hydrochloride (Alphapharm) ... (Nov, 20, 2008)
|
Acetaminophen And Codeine Phosphate (... for Pain - Bones (Nov, 20, 2008)
|
Cleocin Hydrochloride (Pharmacia And ... for Chronic Sinusitis (Nov, 20, 2008)
|
Side effects comparison of Methylprednisolone (Cadista Pharms) -... (Nov, 20, 2008)
|
Actonel for Osteoporosis (Nov, 20, 2008)
|
Clozapine (Caraco) - 100MG for Shizofrenia (Nov, 20, 2008)
|
Casodex (Astrazeneca) - 50MG for Prostate Cancer (Nov, 20, 2008)
|
Side effects comparison of Tylenol (Mcneil Cons) - 650MG (Nov, 20, 2008)
|
|
|
|
 |
|
How to use the report?
Bring a copy of this report to a doctor's appointment to ensure drug risks are fully discussed and understood, in the process of risk and benefit assessment.
|
 |
|
ADVERTISEMENT
|
|